Pages that link to "Q35554631"
Jump to navigation
Jump to search
The following pages link to Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system (Q35554631):
Displaying 50 items.
- Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials (Q26738520) (← links)
- Clinical Tools to Assess and Monitor Spondyloarthritis (Q26866120) (← links)
- Syndesmophyte growth in ankylosing spondylitis (Q28085617) (← links)
- Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort (Q30725992) (← links)
- Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort (Q30990351) (← links)
- Body mass index is related with the presence of syndesmophyte in axial spondyloarthritis: Data from the Korean College of Rheumatology BIOlogics (KOBIO) registry (Q31146997) (← links)
- Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis. (Q33767110) (← links)
- Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis (Q33775550) (← links)
- Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial (Q33801148) (← links)
- The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis (Q33806334) (← links)
- Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis. (Q34046853) (← links)
- Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials (Q34403448) (← links)
- Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis (Q34568353) (← links)
- Spondyloarthritides: evolving therapies (Q34613907) (← links)
- Analysis of PPARGC1B, RUNX3 and TBKBP1 polymorphisms in Chinese Han patients with ankylosing spondylitis: a case-control study (Q34700366) (← links)
- JARID1A, JMY, and PTGER4 polymorphisms are related to ankylosing spondylitis in Chinese Han patients: a case-control study (Q34999325) (← links)
- Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort (Q35165774) (← links)
- Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab (Q35554794) (← links)
- Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? (Q35555802) (← links)
- Predictive factors of radiographic progression in ankylosing spondylitis (Q35626275) (← links)
- ASAS/EULAR recommendations for the management of ankylosing spondylitis (Q35637012) (← links)
- Determinants of hyperkyphosis in patients with ankylosing spondylitis (Q35637200) (← links)
- Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis (Q35750515) (← links)
- Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes (Q35954535) (← links)
- Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort (Q36009390) (← links)
- Improved precision of syndesmophyte measurement for the evaluation of ankylosing spondylitis using CT: a phantom and patient study (Q36187076) (← links)
- Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis (Q36215822) (← links)
- Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis (Q36235821) (← links)
- Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study (Q36245785) (← links)
- Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment (Q36245947) (← links)
- Cervical vertebral squaring in patients without spondyloarthritis (Q36288574) (← links)
- High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation (Q36346823) (← links)
- Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis (Q36458447) (← links)
- Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease (Q36522063) (← links)
- IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients (Q36611562) (← links)
- Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? (Q36633205) (← links)
- Quantitative measures to assess patients with rheumatic diseases: 2006 update (Q36780940) (← links)
- Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)? (Q36903420) (← links)
- Advances in musculoskeletal imaging and their clinical utility in the early diagnosis of spondyloarthritis (Q36960217) (← links)
- Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis (Q37020537) (← links)
- Axial disease in psoriatic arthritis (Q37051508) (← links)
- JMY polymorphism is related to severity of ankylosing spondylitis in Chinese Han patients (Q37067021) (← links)
- Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. (Q37215981) (← links)
- Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics (Q37279373) (← links)
- Quantitative syndesmophyte measurement in ankylosing spondylitis using CT: longitudinal validity and sensitivity to change over 2 years (Q37348736) (← links)
- Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years (Q37350944) (← links)
- Imaging of the sacroiliac joint involvement in seronegative spondylarthropathies (Q37519348) (← links)
- Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study (Q37539712) (← links)
- Clinical assessment and outcome research in spondyloarthritis (Q37601570) (← links)
- Tools for monitoring spondyloarthritis in clinical practice (Q37608920) (← links)